Tumor PD-L1 expression and molecular profiling are not associated with immune checkpoint inhibitor-induced thyroid dysfunction in advanced NSCLC patients

por Horesh, Adi, Pollack, Rena, Nechushtan, Hovav, Dresner-Pollak, Rivka, Neuman, Tzahi
Publicado 2023